脑MR波谱在I型Crigler-Najjar综合征患儿中的附加价值:与人口学、神经发育及实验室指标的相关性
前瞻性研究纳入25例I型Crigler-Najjar综合征(CNs-I)患儿和25例年龄性别匹配对照,行基底节多体素1H-MRS(TE 135-144 ms)。患者NAA/Cr和Ch/Cr与对照差异显著,鉴别截断值分别为1.8和1.2(AUC 0.91、0.84);鉴别有无神经发育延迟的截断值为1.47和0.99(AUC 0.87、0.8)。NAA/Cr和Ch/Cr与家族史、近亲婚配、神经发育延迟、血清胆红素、光疗及输血相关。
要点
- CNs-I患儿基底节NAA/Cr和Ch/Cr较对照显著降低,可用于识别脑微结构改变。
- NAA/Cr≤1.8、Ch/Cr≤1.2提示CNs-I可能,AUC分别为0.91和0.84。
- NAA/Cr≤1.47、Ch/Cr≤0.99提示合并神经发育延迟,AUC分别为0.87和0.8。
关键影像表现/征象
- CNs-I患儿基底节NAA/Cr和Ch/Cr较对照显著降低。
- 合并神经发育延迟的CNs-I患儿NAA/Cr和Ch/Cr较无神经发育延迟者显著降低。
诊断标准与关键数值
- NAA/Cr和Ch/Cr鉴别CNs-I与对照的截断值分别为1.8和1.2,AUC分别为0.91和0.84。
- NAA/Cr和Ch/Cr鉴别CNs-I患儿有无神经发育延迟的截断值分别为1.47和0.99,AUC分别为0.87和0.8。
- NAA/Cr与血清胆红素相关(r=-0.77,p<0.001),Ch/Cr与血清胆红素相关(r=-0.49,p=0.014)。
- NAA/Cr与家族史、近亲婚配、神经发育延迟、光疗、输血相关(p=0.006、p<0.001、p=0.001、p<0.001、p<0.001)。
- Ch/Cr与家族史、近亲婚配、神经发育延迟、输血相关(p<0.001、p=0.001、p=0.004、p=0.001),与光疗相关(p=0.32)。
临床应用与阅片要点
- 对CNs-I患儿行基底节多体素1H-MRS,关注NAA/Cr和Ch/Cr降低,辅助识别脑微结构改变。
- NAA/Cr和Ch/Cr降低程度与神经发育延迟、血清胆红素水平相关,可提示临床关注神经发育评估。
- 判读时注意TE 135-144 ms条件,截断值基于本组CNs-I患儿,外推需谨慎。
局限性
- 单中心前瞻性研究,样本量25例,结论外推需谨慎。
- 原文未报告其他明显局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study is to demonstrate the role of proton magnetic resonance spectroscopy (1H-MRS) in the detection of brain microstructural changes in patients with Crigler-Najjar syndrome type-I (CNs-I), and its correlation with demographic, neurodevelopmental and laboratory findings.
METHODS: Prospective study was conducted on 25 children with CNs-I and 25 age and sex-matched children, who served as control. They underwent multivoxel 1H-MRS of basal ganglion at echo time 135-144 ms. N-acetyl aspartate/Creatine (NAA/Cr) and Choline (Ch)/Cr were calculated and correlated with demographic, clinical, and laboratory findings of patients with CNs-I.
RESULTS: There was a significant difference in NAA/Cr and Ch/Cr between patients and controls. The cut-off value for NAA/Cr and Ch/Cr used to differentiate patients from controls were 1.8 and 1.2 with an area under the curve (AUC) of 0.91 and 0.84 respectively. There was a significant difference in MRS ratios between patients with neurodevelopmental delay (NDD) and patients without NDD. The cut-off values for NAA/Cr and Ch/Cr used to differentiate between patients with NDD and patients without NDD were 1.47 and 0.99, with AUC of 0.87 and 0.8 respectively. The NAA/Cr and Ch/Cr were well correlated with family history (p = 0.006 and p < 0.001) respectively, consanguinity (p < 0.001 and p = 0.001), neurodevelopmental delay (p = 0.001 and p = 0.004), serum bilirubin level (r = -0.77, p < 0.001), (r = -0.49, p = 0.014), phototherapy (p < 0.001 and p = 0.32), blood transfusion (p < 0.001 and p = 0.001) respectively.
CONCLUSION: 1H-MRS can be a useful tool in the detection of neurological changes in patients with CNs-I; NAA/Cr and Ch/Cr parameters are well correlated with demographic, clinical, and laboratory findings.
ADVANCES IN KNOWLEDGE: Our study is the first report on using MRS in assessing neurological manifestations in CNs. 1H-MRS can be a useful tool in the detection of neurological changes in patients with CNs-I.
引用
- Alnaghy, Taman, Abdelhalim, et al. The added value of brain MR spectroscopy in children with Crigler-Najjar syndrome type-I: correlation with demographic, neurodevelopmental, and laboratory findings. Br J Radiol. 2023. PMID: 36809151. doi:10.1259/bjr.20220433
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。